Resonant Therapeutics, Inc.
Montecito, CA
- UEI
- Q7NGQLBLYVY4
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 259 Butterfly Ln, Montecito, CA 93108, USA
- Website
- resonantrx.com
- Founded
- 2015
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel nectin targeting antibody-drug conjugate for ovarian cancer therapy - project summary/abstract… | National Cancer Institute | $371,070 |
Quick answers
What is Resonant Therapeutics, Inc.'s UEI?
Resonant Therapeutics, Inc.'s Unique Entity ID (UEI) in SAM.gov is Q7NGQLBLYVY4.
Where is Resonant Therapeutics, Inc. located?
Resonant Therapeutics, Inc.'s physical address in SAM.gov is 259 Butterfly Ln, Montecito, CA 93108, USA.
Is Resonant Therapeutics, Inc. registered in SAM.gov?
Resonant Therapeutics, Inc.'s SAM.gov registration expired on May 7, 2026.
What is Resonant Therapeutics, Inc.'s most recent federal award?
Resonant Therapeutics, Inc.'s most recent federal grant award is Development of a novel nectin targeting antibody-drug conjugate for ovarian cancer therapy - project summary/abstract… (R43CA287873), from National Cancer Institute, on September 19, 2024.
On GovTribe
See Resonant Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors